Published in Crit Care Med on January 01, 1995
Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin Microbiol Rev (2003) 3.70
Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit Care (2006) 3.19
ESAT-6 subunit vaccination against Mycobacterium tuberculosis. Infect Immun (2000) 2.87
MicroRNA in TLR signaling and endotoxin tolerance. Cell Mol Immunol (2011) 1.86
Pulmonary and hepatic gene expression following cecal ligation and puncture: monophosphoryl lipid A prophylaxis attenuates sepsis-induced cytokine and chemokine expression and neutrophil infiltration. Infect Immun (1998) 1.49
Lipopolysaccharide and monophosphoryl lipid A differentially regulate interleukin-12, gamma interferon, and interleukin-10 mRNA production in murine macrophages. Infect Immun (1997) 1.15
The immunobiology of toll-like receptor 4 agonists: from endotoxin tolerance to immunoadjuvants. Shock (2013) 1.12
Elevation in body temperature to fever range enhances and prolongs subsequent responsiveness of macrophages to endotoxin challenge. PLoS One (2012) 1.06
Endotoxemia and endotoxin tolerance in patients with ARDS. Langenbecks Arch Surg (2008) 1.04
Mechanism of impaired NLRP3 inflammasome priming by monophosphoryl lipid A. Sci Signal (2011) 1.03
Effect of major abdominal surgery on endotoxin release and expression of Toll-like receptors 2/4. Langenbecks Arch Surg (2008) 0.88
Effects of aging on endotoxin tolerance induced by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli. PLoS One (2012) 0.87
N-linked glycosylation is required for c1 inhibitor-mediated protection from endotoxin shock in mice. Infect Immun (2004) 0.83
Lipid A-mediated tolerance and cancer therapy. Adv Exp Med Biol (2010) 0.80
Monophosphoryl lipid A provides biphasic cardioprotection against ischaemia-reperfusion injury in rat hearts. Br J Pharmacol (1999) 0.78
Vaccine technologies: From whole organisms to rationally designed protein assemblies. Biochem Pharmacol (2016) 0.78
Monophosphoryl Lipid A: A Novel Agent for Inducing Pharmacologic Myocardial Preconditioning. J Thromb Thrombolysis (1996) 0.77
Lipid A-mediated tolerance and cancer therapy. Adv Exp Med Biol (2009) 0.77
Peroxisome proliferator activated receptor gamma is not necessary for the development of LPS-induced tolerance in macrophages. Immunology (2007) 0.76
Comparative Transcriptome Profiles of Human Blood in Response to the Toll-like Receptor 4 Ligands Lipopolysaccharide and Monophosphoryl Lipid A. Sci Rep (2017) 0.75
Immune dysfunction in patients with obstructive jaundice before and after endoscopic retrograde cholangiopancreatography. Clin Sci (Lond) (2016) 0.75
Monophosphoryl lipid A induces protection against LPS in medullary thick ascending limb through a TLR4-TRIF-PI3K signaling pathway. Am J Physiol Renal Physiol (2017) 0.75
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol (2000) 13.29
Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors. Science (1997) 4.70
SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res (1999) 4.23
Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J Biol Chem (1995) 3.13
Transformation and DNA size. I. Activity of fragments of defined size and a fit to a random double cross-over model. J Mol Biol (1968) 3.12
Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia (2005) 3.10
Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med (2000) 3.00
Reaction of endotoxin and surfactants. I. Physical and biological properties of endotoxin treated with sodium deoxycholate. J Bacteriol (1966) 2.86
End-tidal carbon dioxide concentration during cardiopulmonary resuscitation. N Engl J Med (1988) 2.80
SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors. Cancer Res (2000) 2.39
Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Crit Care Med (1983) 2.36
Roles for Fgf signaling during zebrafish fin regeneration. Dev Biol (2000) 2.36
Preparation and properties of a national reference endotoxin. J Clin Microbiol (1976) 2.30
Physical aspects of reversible inactivation of endotoxin. Ann N Y Acad Sci (1966) 2.21
Characterization of c-Ki-ras oncogene alleles by direct sequencing of enzymatically amplified DNA from carcinogen-induced tumors. Proc Natl Acad Sci U S A (1987) 1.98
Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival. FASEB J (2001) 1.86
Decreases in mortality on a large urban medical service by facilitating access to critical care. An alternative to rationing. Arch Intern Med (1988) 1.86
Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms. Cancer Res (2001) 1.80
Molecular immunogenicity of bacterial lipopolysaccharide antigens: establishing a quantitative system. J Immunol (1971) 1.75
Venous hypercarbia associated with severe sepsis and systemic hypoperfusion. Crit Care Med (1990) 1.74
Antibodies with specificity to native gp120 and neutralization activity against primary human immunodeficiency virus type 1 isolates elicited by immunization with oligomeric gp160. J Virol (1997) 1.72
Cardiac output and end-tidal carbon dioxide. Crit Care Med (1985) 1.71
Design, synthesis, and evaluations of substituted 3-[(3- or 4-carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as inhibitors of VEGF, FGF, and PDGF receptor tyrosine kinases. J Med Chem (1999) 1.70
Difference in acid-base state between venous and arterial blood during cardiopulmonary resuscitation. N Engl J Med (1986) 1.66
Frequency of occurrence of native hapten among enterobacterial species. J Bacteriol (1966) 1.66
Relationship of oxygen delivery and mixed venous oxygenation to lactic acidosis in patients with sepsis and acute myocardial infarction. Crit Care Med (1988) 1.58
FGF10 is an inducer and Pax6 a competence factor for lacrimal gland development. Development (2000) 1.57
Flk-1 as a target for tumor growth inhibition. Cancer Res (1996) 1.56
Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy. Cancer Res (2001) 1.55
Bronchial compression as a result of lung herniation after pneumonectomy. Thorax (1991) 1.53
Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases. J Med Chem (1998) 1.52
Expired carbon dioxide: a noninvasive monitor of cardiopulmonary resuscitation. Circulation (1988) 1.50
Transformation and DNA size: two controlling parameters and the efficiency of the single strand intermediate. Cold Spring Harb Symp Quant Biol (1968) 1.48
Effect of crystalloid and colloid solutions on blood rheology in sepsis. Shock (1997) 1.48
Alteration of physical, chemical, and biological properties of endotoxin by treatment with mild alkali. J Bacteriol (1969) 1.48
Meticillin-resistant Staphylococcus aureus blood-stream infection among patients attending the emergency department of an urban tertiary-referral hospital. Ir Med J (2007) 1.47
Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal development. FASEB J (2001) 1.44
Enhancement of endotoxic shock by N-acetylmuramyl-L-alanyl-(L-seryl)-D-isoglutamine (muramyl dipeptide). Cancer Res (1979) 1.44
Limitations to the identification of HIV-associated neurocognitive disorders in clinical practice. HIV Med (2013) 1.44
Alterations in C3, C4, factor B, and related metabolites in septic shock. Clin Immunol Immunopathol (1993) 1.44
Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection. Circulation (2001) 1.42
Unaccounted for anion in metabolic acidosis during severe sepsis in humans. Crit Care Med (1991) 1.40
Competent and continuing care of the critically ill. Crit Care Med (1988) 1.39
The first decade of the American Board of Internal Medicine certification in critical care medicine: an overview of examinees and certificate holders from 1987 through 1996. Crit Care Med (2000) 1.38
Monophosphoryl lipid A attenuates the effects of endotoxic shock in pigs. J Lab Clin Med (1992) 1.38
Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide. Clin Cancer Res (1997) 1.36
Epidemic cholera in the Amazon: the challenge of preventing death. Am J Trop Med Hyg (1993) 1.35
Erythromycin uptake and accumulation by human polymorphonuclear leukocytes and efficacy of erythromycin in killing ingested Legionella pneumophila. J Infect Dis (1984) 1.34
Induction and characterization of -galactosidase in an extreme thermophile. J Bacteriol (1972) 1.32
Physical structure of a native protoplasmic polysaccharide from Escherichia coli. J Immunol (1967) 1.32
Inactivation of suppressor T-cell activity by nontoxic monophosphoryl lipid A. Infect Immun (1988) 1.31
Tyrphostins. 5. Potent inhibitors of platelet-derived growth factor receptor tyrosine kinase: structure-activity relationships in quinoxalines, quinolines, and indole tyrphostins. J Med Chem (1996) 1.27
Septic shock. Lancet (1998) 1.26
Hybrid formation between bacterial endotoxins. J Exp Med (1967) 1.26
Arteriovenous carbon dioxide and pH gradients during cardiac arrest. Circulation (1986) 1.24
HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160. J Immunol (1998) 1.22
Duration of survival for disseminated malignant melanoma: results of a meta-analysis. Melanoma Res (2000) 1.22
Alteration and restoration of endotoxin activity after complexing with plasma proteins. J Bacteriol (1966) 1.19
Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock. Crit Care Med (2001) 1.19
Acute pulmonary edema in Plasmodium falciparum malaria. Am Rev Respir Dis (1978) 1.19
Human liver protein map: a reference database established by microsequencing and gel comparison. Electrophoresis (1992) 1.18
The 1918-1920 influenza pandemic in Peru. Vaccine (2011) 1.17
Immunological responses of mice to native protoplasmic polysaccharide and lipopolysaccharide: functional separation of the two signals required to stimulate a secondary antibody response. J Exp Med (1974) 1.17
Safety and pharmacokinetics of multiple doses of intravenous ofloxacin in healthy volunteers. Antimicrob Agents Chemother (1992) 1.16
Decreased response to recall antigens is associated with depressed costimulatory receptor expression in septic critically ill patients. J Lab Clin Med (2000) 1.15
Microcalcifications in breast cancer: novel insights into the molecular mechanism and functional consequence of mammary mineralisation. Br J Cancer (2012) 1.14
Optimum left heart filling pressure during fluid resuscitation of patients with hypovolemic and septic shock. Crit Care Med (1983) 1.14
Arterial PCO2 as an indicator of systemic perfusion during cardiopulmonary resuscitation. Crit Care Med (1989) 1.13
Identification of an activated c-Ki-ras oncogene in rat liver tumors induced by aflatoxin B1. Proc Natl Acad Sci U S A (1986) 1.13
Comparison of blood lactate concentrations in central venous, pulmonary artery, and arterial blood. Crit Care Med (1987) 1.12
Modification of selected host-reactive properties of endotoxin by treatment with sodium deoxycholate. J Bacteriol (1968) 1.12
Altered leukocyte immunophenotypes in septic shock. Studies of HLA-DR, CD11b, CD14, and IL-2R expression. Chest (1993) 1.12
Mode of action of oxathiin systemic fungicides. V. Effect on electron transport system of Ustilago maydis and Saccharomyces cerevisiae. J Bacteriol (1972) 1.11
Endotoxin-cell-membrane interactions leading to transmembrane signaling. Contemp Top Mol Immunol (1981) 1.11
End-tidal CO2 as a guide to successful cardiopulmonary resuscitation: a preliminary report. Crit Care Med (1985) 1.11
Buffer agents do not reverse intramyocardial acidosis during cardiac resuscitation. Circulation (1990) 1.10
Topological properties of two cubic phases of a phospholipid:cholesterol:diacylglycerol aqueous system and their possible implications in the phospholipase C-induced liposome fusion. FEBS Lett (1995) 1.10
Weekly dosing with the platelet-derived growth factor receptor tyrosine kinase inhibitor SU9518 significantly inhibits arterial stenosis. Circ Res (2001) 1.10
Antibody responses of mice to alkaline detoxifield lipopolysaccharide. J Immunol (1976) 1.10
Immunological responses of mice to lipopolysaccharide: lack of secondary responsiveness by C3H/HeJ mice. Infect Immun (1977) 1.09
Ability of monophosphoryl lipid A to augment the antibody response of young mice. Infect Immun (1988) 1.09
Pulmonary artery sling: a new diagnostic tool and clinical review. Pediatrics (1982) 1.08
Triage considerations in medical intensive care. Arch Intern Med (1990) 1.07
Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype. J Am Soc Nephrol (1998) 1.06
Cubic phases of lipid-containing systems. Elements of a theory and biological connotations. J Mol Biol (1993) 1.06
Microvascular function and rheologic changes in hyperdynamic sepsis. Crit Care Med (1995) 1.06
Immune interferon induction by T-cell mitogens involves different T-cell subpopulations. Cell Immunol (1979) 1.06
Can garlic reduce levels of serum lipids? A controlled clinical study. Am J Med (1993) 1.06
Cardiopulmonary resuscitation in the rat. J Appl Physiol (1985) (1988) 1.06
Using a knowledge, attitudes and practices survey to supplement findings of an outbreak investigation: cholera prevention measures during the 1991 epidemic in Peru. Int J Epidemiol (1996) 1.05
Ajoene, the antiplatelet principle of garlic, synergistically potentiates the antiaggregatory action of prostacyclin, forskolin, indomethacin and dypiridamole on human platelets. Thromb Res (1986) 1.05
Modulation of the immune response to lipopolysaccharide. J Immunol (1982) 1.04
Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration. Vaccine (2000) 1.04
Effects of high resistance training in patients with myotonic dystrophy. Scand J Rehabil Med (1999) 1.04
Spontaneous microdeletions and microinsertions in a transgenic mouse mutation detection system: analysis of age, tissue, and sequence specificity. Environ Mol Mutagen (2001) 1.04
Use of thymosin in the treatment of primary immunodeficiency diseases and cancer. Med Clin North Am (1976) 1.02